Skip to main content Skip to main navigation menu Skip to site footer
Reumatismo

Editor-in-Chief: M.A. Cimmino, Genova, Italy | eISSN 2240-2683

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Early Access
  • Archives
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News
1.2
Impact Factor
2025
1.5
CiteScore
2025
This journal has not published any issues.
1.2
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

    U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco
    268-274
    https://doi.org/10.4081/reumatismo.2006.268
    1870
    Downloads: 2844
  • Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

    P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni
    290-295
    https://doi.org/10.4081/reumatismo.2008.290
    2375
    Downloads: 1235
  • PO:06:081 | Safety of JAK inhibitors compared to non-TNF-targeted biologic therapies in rheumatoid arthritis patients who are inadequate responders to TNF inhibitors Lorenzo Di Luozzo1, Alessandro Giollo1, Mariangela Salvato1, Francesca Frizzera1, Kiren Khalid1, Margherita Zen1, Andrea Doria1 | 1Azienda ospedaliera universitaria di Padova, unità di Reumatologia, Padova, Italy

    Società Italiana di Reumatologia
    18-03-2026
    https://doi.org/10.4081/reumatismo.2025.2298
    127
  • Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide

    M. Fabris, B. Tolusso, E. Gremese, P. Tomietto, G. Ferraccioli
    94-103
    https://doi.org/10.4081/reumatismo.2004.94
    1591
    Downloads: 1053
  • PO:36:252 | Long-Term Outcomes of Patients with Takayasu Arteritis in the Era of Biological Agents: a Multicenter International Study Alessandro Tomelleri1, Durga Prasanna Misra2, Fatma Alibaz-Oner3, Chiara Marvisi4, Chiara Calabrese1, Upendra Rathore2, Aysegul Avcu3, Adele Del Giudice4, Elisabetta Olivi4, Caterina Ricordi4, Corrado Campochiaro1, Elena Baldissera1, Marco Matucci-Cerinic1, Haner Direskeneli3, Carlo Salvarani4, Lorenzo Dagna1 | 1IRCCS Ospedale San Raffaele, Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare Milano, Italy; 2Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGIMS, Clinical Immunology and Rheumatology Lucknow Country, India; 3Marmara University, School of Medicine, Department of Internal Medicine, Division of Rheumatology Istanbul, Turkey; 4Azienda USL-IRCCS di Reggio Emilia, Unità di Reumatologia Reggio Emilia, Italy

    Società Italiana di Reumatologia
    18-03-2026
    https://doi.org/10.4081/reumatismo.2025.2389
    114
  • Delayed referral, socioeconomic status, and disease characteristics as factors associated with disabilities in rheumatoid arthritis patients: a multicenter observational study

    Chandrashekara S, Sapan Pandya, Padmanabha Shenoy, Uma Kumar, Alakendu Ghosh, Rajkiran Dudam, Apurva Khare, Banwari Lal Sharma, Rudra Prosad Goswami
    25-06-2026
    https://doi.org/10.4081/reumatismo.2026.1852
    1280
    Downloads: 209
  • Kidney involvement in rheumatoid arthritis

    A. Icardi, P. Araghi, M. Ciabattoni, U. Romano, P. Lazzarini, G. Bianchi
    76-85
    https://doi.org/10.4081/reumatismo.2003.76
    6010
    Downloads: 7966
  • PO:01:006 | Increased risk of cancer recurrence or mortality associated with DMARDs? Laura Scagnellato1, Giacomo Cozzi1, Mariagrazia Lorenzin1, Mariangela Salvato1, Alessandro Giollo1, Bernd Raffeiner1, Antonia Calligaro1, Teresa Del Ross1, Sara Bindoli1, Margherita Zen1, Paolo Sfriso1, Andrea Doria1, Roberta Ramonda1. | 1UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Padova, Italy.

    Società Italiana di Reumatologia
    25-11-2025
    https://doi.org/10.4081/reumatismo.2025.2003
    243
  • New classification criteria for rheumatoid arthritis

    C.A. Scirè, R. Caproali
    159-162
    https://doi.org/10.4081/reumatismo.2010.159
    2858
    Downloads: 9142
  • Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

    A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini
    233-238
    https://doi.org/10.4081/reumatismo.2006.233
    1193
    Downloads: 1133
51 - 60 of 60 items << < 1 2 
Make a Submission

authors

FOR AUTHORS
  • ARTICLE PROCESSING CHARGE
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
  • Thanks to Reviewers

Categories

    • Abstract Book
    • Oral Communications - Day 1
    • Posters - Day 1
    • Oral Communications - Day 2
    • Posters - Day 2
    • Oral Communications - Day 3

indexing

INDEXING
  • PubMed
  • Scopus
  • Web of Science
  • Google Scholar
  • OpenAlex
  • Scilit
  • DOAJ
  • Società Italiana di Reumatologia
  • Analytics

social

Follow Reumatismo on

Keywords

Reumatismo

is the Official Journal of the Italian Society of Rheumatology (SIR). Founded in 1949. Published online by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 0048-7449
eISSN: 2240-2683

Info

  • About
  • Editorial Board
  • News
  • Advertising

Submissions

  • Submission
  • Guidelines For Authors

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.